Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-033681
Filing Date
2006-05-30
Accepted
2006-05-30 17:23:09
Documents
1
Period of Report
2006-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 OF J.J. FINKELSTEIN (MAY 26, 2006) rrd119911.html 4  
1 FORM 4 OF J.J. FINKELSTEIN (MAY 26, 2006) rrd119911.xml 4 8584
  Complete submission text file 0001181431-06-033681.txt   10560
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA 1 BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHSEDA MD 20814 3019611992
FINKELSTEIN J J (Reporting) CIK: 0001125610 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 06875028